The chemical class known as LOC100040524 Inhibitors comprises a series of compounds specifically engineered to target and inhibit the activity of the gene product expressed by LOC100040524. This gene, discovered through in-depth genomic research, is recognized for its involvement in a range of cellular processes. The functionality of LOC100040524 is noted for being highly context-dependent, meaning its role can vary based on the specific cellular environment and external stimuli it encounters. The inhibitors designed for this gene are unique in their mechanism of action; they are tailored to bind selectively to the proteins or enzymes that result from the expression of LOC100040524. This binding is a key aspect of their function, as it directly impacts the biochemical pathways in which the LOC100040524 gene product participates. By modulating the activity of this gene product, these inhibitors aim to influence the associated cellular processes and outcomes.
Developing LOC100040524 Inhibitors involves a multidisciplinary approach, integrating insights from molecular biology, biochemistry, and pharmacology. The first step in this process is acquiring a comprehensive understanding of the structural and functional characteristics of the LOC100040524 gene product. Techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are employed to gain a detailed understanding of the target molecule. This knowledge is crucial for the rational design of inhibitors that are both effective in their interaction and highly selective for their target. Typically, these inhibitors are small molecules, strategically designed to penetrate cellular membranes efficiently and establish a stable and potent interaction with their target. The molecular structure of these inhibitors is carefully optimized to ensure a strong interaction with the target molecule, typically involving hydrogen bonds, hydrophobic interactions, and van der Waals forces. The efficacy of these inhibitors is evaluated through various biochemical assays in vitro. These assays are critical for determining the potency, specificity, and overall behavior of the inhibitors under controlled experimental conditions. This research provides vital insights into the inhibitors' mechanism of action, laying the foundation for further exploration of their interaction dynamics and potential impact on cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway which is involved in transcriptional and translational regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which could downregulate protein synthesis and affect gene expression indirectly. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, which may lead to reduced activation of transcription factors and thus inhibit gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially affecting AP-1 transcription factor activity and gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, which might alter the expression of genes regulated by this pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can alter cellular regulatory mechanisms impacting gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, which could affect numerous signaling pathways and gene expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Inhibits Hsp90 which could impact multiple signaling pathways and possibly gene expression. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
An analog of geldanamycin, inhibiting Hsp90 and potentially affecting gene expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Inhibits MDM2, potentially increasing p53 activity and altering gene expression related to p53 response elements. | ||||||